The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
Category: Oncology
Ovarian cancer is the fifth leading cause of deaths from cancer in women
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
The pilot will see GP practices look at patient records to identify those most at risk
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
The UK National Institute for Health and Care Excellence has recommended a targeted twice daily drug treatment that […]
The model could lead to more targeted treatments for the disease
What is Enhertu?Trastuzumab deruxtecan (Enhertu), made by Daiichi Sankyo and AstraZeneca, is a treatment for adult patients with […]